Straits Times Index
3,173.93 -13.73 (-0.43%) Nikkei
37,068.35 -1,011.35 (-2.65%) Hang Seng
16,185.37 -200.50 (-1.22%) FTSE 100
7,877.05 +29.06 (+0.37%) Bitcoin USD
62,001.32 +840.69 (+1.37%) CMC Crypto 200
1,280.35 -32.27 (-2.46%)
Ginkgo Bioworks Holdings, Inc. (DNA)
After hours:
| Previous close | 0.8716 |
| Open | 0.8660 |
| Bid | 0.0000 x 1400 |
| Ask | 0.0000 x 1300 |
| Day's range | 0.8520 - 0.9541 |
| 52-week range | 0.8500 - 2.5450 |
| Volume | |
| Avg. volume | 23,088,301 |
| Market cap | 1.99B |
| Beta (5Y monthly) | 1.36 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.4600 |
| Earnings date | 01 Mar 2024 - 05 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.92 |
PR NewswireIl Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
Il Granaio delle Idee (IGDI), an innovative international developer and provider of clean label baking ingredients, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new collaboration. IGDI has identified a new sourdough bakery strain that can improve the flavor and aroma profile of baked goods via its starter culture product, Pater®. This collaboration will leverage Ginkgo's Adaptive Laboratory Evolution (ALE) technol
PR NewswireGinkgo Bioworks Announces Acquisition of AgBiome's Platform Assets
Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of AgBiome's platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline. These assets will be integrated into Ginkgo Ag Biologicals Services, established with the acquisition of a Bayer agricultural biologicals R&D fa
PR NewswireGinkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"
Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, is hosting its 5th annual Ferment conference. The conference brings together stakeholders from across the synthetic biology community, including R&D leaders, Ginkgo Technology Network partners, experts from across academia, journalists, and many more. Because the event has reached its in-person capacity limits, a livestream will be available on Ginkgo's YouTube page and Ginkgo's Inves
